...
search icon
sny-img

Sanofi ADR, Common Stock

SNY

NSQ

$50.9

+$0.34

(0.67%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$126.61B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
20.3052
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.86M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
4.03%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.48
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$45.79 L
$60.12 H
$50.9

About Sanofi ADR, Common Stock

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, yellow fever, and rabies vaccines. In addition, the company has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Innate Pharma SA for a natural killer cell engager program targeting B7-H3; and Blackstone Life Sciences to develop pivotal studies and clinical development program. Further, it has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop novel targeted protein degradation therapies; Denali Therapeutics Inc. to treat a range of systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for the discovery and development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameSNYSectorS&P500
1-Week Return2.5%1.04%0.24%
1-Month Return-13.61%-7.14%-7.32%
3-Month Return0.32%-2.78%-12.05%
6-Month Return-7.22%-10.56%-9.73%
1-Year Return10.39%-1.55%5.05%
3-Year Return-7.77%-0.6%20.03%
5-Year Return6.6%35.24%83.31%
10-Year Return-1.51%85.96%153.54%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue37.37B39.17B45.39B46.03B44.29B[{"date":"2020-12-31","value":81.18,"profit":true},{"date":"2021-12-31","value":85.1,"profit":true},{"date":"2022-12-31","value":98.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":96.2,"profit":true}]
Cost of Revenue12.16B12.26B13.69B14.24B13.21B[{"date":"2020-12-31","value":85.4,"profit":true},{"date":"2021-12-31","value":86.08,"profit":true},{"date":"2022-12-31","value":96.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":92.76,"profit":true}]
Gross Profit25.21B26.92B31.70B31.80B31.08B[{"date":"2020-12-31","value":79.29,"profit":true},{"date":"2021-12-31","value":84.66,"profit":true},{"date":"2022-12-31","value":99.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":97.75,"profit":true}]
Gross Margin67.47%68.72%69.83%69.07%70.18%[{"date":"2020-12-31","value":96.13,"profit":true},{"date":"2021-12-31","value":97.91,"profit":true},{"date":"2022-12-31","value":99.5,"profit":true},{"date":"2023-12-31","value":98.42,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses17.32B17.77B19.81B23.94B23.83B[{"date":"2020-12-31","value":72.34,"profit":true},{"date":"2021-12-31","value":74.23,"profit":true},{"date":"2022-12-31","value":82.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":99.53,"profit":true}]
Operating Income8.08B8.13B16.79B7.88B7.25B[{"date":"2020-12-31","value":48.12,"profit":true},{"date":"2021-12-31","value":48.39,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":46.89,"profit":true},{"date":"2024-12-31","value":43.18,"profit":true}]
Total Non-Operating Income/Expense(313.00M)(656.00M)(400.00M)(1.36B)(1.11B)[{"date":"2020-12-31","value":-31300000000,"profit":false},{"date":"2021-12-31","value":-65600000000,"profit":false},{"date":"2022-12-31","value":-40000000000,"profit":false},{"date":"2023-12-31","value":-136100000000,"profit":false},{"date":"2024-12-31","value":-111400000000,"profit":false}]
Pre-Tax Income13.80B7.80B10.49B7.15B6.70B[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":56.49,"profit":true},{"date":"2022-12-31","value":75.99,"profit":true},{"date":"2023-12-31","value":51.82,"profit":true},{"date":"2024-12-31","value":48.52,"profit":true}]
Income Taxes1.81B1.56B2.01B1.60B1.20B[{"date":"2020-12-31","value":90.38,"profit":true},{"date":"2021-12-31","value":77.67,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":79.86,"profit":true},{"date":"2024-12-31","value":60.02,"profit":true}]
Income After Taxes11.99B6.24B8.48B5.55B5.49B[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":52.04,"profit":true},{"date":"2022-12-31","value":70.75,"profit":true},{"date":"2023-12-31","value":46.29,"profit":true},{"date":"2024-12-31","value":45.82,"profit":true}]
Income From Continuous Operations12.35B6.28B6.83B5.44B5.55B[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":50.84,"profit":true},{"date":"2022-12-31","value":55.33,"profit":true},{"date":"2023-12-31","value":44.02,"profit":true},{"date":"2024-12-31","value":44.97,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income12.29B6.22B8.37B5.40B5.56B[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":50.62,"profit":true},{"date":"2022-12-31","value":68.09,"profit":true},{"date":"2023-12-31","value":43.92,"profit":true},{"date":"2024-12-31","value":45.23,"profit":true}]
EPS (Diluted)3.413.874.325.774.15[{"date":"2020-12-31","value":59.1,"profit":true},{"date":"2021-12-31","value":67.07,"profit":true},{"date":"2022-12-31","value":74.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":71.96,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SNY
Cash Ratio 0.27
Current Ratio 1.46
Quick Ratio 1.14

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SNY
ROA (LTM) 4.28%
ROE (LTM) 7.30%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SNY
Debt Ratio Lower is generally better. Negative is bad. 0.41
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.58

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SNY
Trailing PE 20.52
Forward PE 10.83
P/S (TTM) 2.86
P/B 1.42
EV/R 2.72
EV/Ebitda 10.91
PEG 0.87

FAQs

What is Sanofi ADR share price today?

Sanofi ADR (SNY) share price today is $50.9

Can Indians buy Sanofi ADR shares?

Yes, Indians can buy shares of Sanofi ADR (SNY) on Vested. To buy Sanofi ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SNY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Sanofi ADR be purchased?

Yes, you can purchase fractional shares of Sanofi ADR (SNY) via the Vested app. You can start investing in Sanofi ADR (SNY) with a minimum investment of $1.

How to invest in Sanofi ADR shares from India?

You can invest in shares of Sanofi ADR (SNY) via Vested in three simple steps:

  • Click on Sign Up or Invest in SNY stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Sanofi ADR shares
What is Sanofi ADR 52-week high and low stock price?

The 52-week high price of Sanofi ADR (SNY) is $60.12. The 52-week low price of Sanofi ADR (SNY) is $45.79.

What is Sanofi ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Sanofi ADR (SNY) is 20.3052

What is Sanofi ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Sanofi ADR (SNY) is 1.42

What is Sanofi ADR dividend yield?

The dividend yield of Sanofi ADR (SNY) is 4.03%

What is the Market Cap of Sanofi ADR?

The market capitalization of Sanofi ADR (SNY) is $126.61B

What is Sanofi ADR’s stock symbol?

The stock symbol (or ticker) of Sanofi ADR is SNY

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top